Data as of Apr 17
| -0.03 / -0.14%|
The 6 analysts offering 12-month price forecasts for Sagent Pharmaceuticals Inc have a median target of 23.50, with a high estimate of 25.00 and a low estimate of 20.00. The median estimate represents a +11.75% increase from the last price of 21.03.
The current consensus among 7 polled investment analysts is to Hold stock in Sagent Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.